A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall Survival
2-15 years
No
Dennis Carter, MD
Principal Investigator
Rocky Mountain Cancer Centers
United States: Institutional Review Board
WIRB #20040075
NCT01185145
February 2004
August 2024
Name | Location |
---|---|
Rocky Mountain Cancer Centers - Thornton | Thornton, Colorado 80229 |
Rocky Mountain Cancer Centers - Midtown | Denver, Colorado 80218 |
Rocky Mountain Cancer Centers - Aurora | Aurora, Colorado 80012 |
Rocky Mountain Cancer Centers - Littleton | Littleton, Colorado 80120 |
Rocky Mountain Cancer Centers - Boulder | Boulder, Colorado 80303 |
Rocky Mountain Cancer Centers - Sky Ridge | Lone Tree, Colorado 80124 |